Literature DB >> 19579073

Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center.

Yujun Dong1, Jia Na, Jicheng Lv, Rengui Wang, Xixue Chen, Nan Li, Hanyun Ren.   

Abstract

The clinical, pathological treatment, and prognostic data of 55 patients with Castleman disease (CD) were collected retrospectively from a single medical center. Thirty-four cases were classified as uni-centric; the remaining 21 cases were diagnosed as multi-centric CD. Regarding pathological classification, 38 cases were hyaline vascular type, account for 69.1% of all patients. Nine cases were diagnosed as plasmacytic type and eight cases as mixed cellularity type. Several prominent clinical complications were noted in this group of patients with CD: the skin, internal organs, and hematopoietic system were involved individually or concurrently. Clinical complications were distinct between different clinical and pathological subtypes of CD. The unique clinical and laboratory features of patients with paraneoplastic pemphigus suggests this diagnosis should be characterized as an independent disease entity. The presence of clinical complications is an independent prognostic factor in all patients with CD. More effective initial therapy should be considered in patients with CD with complications to improve the overall survival.

Entities:  

Mesh:

Year:  2009        PMID: 19579073     DOI: 10.1080/10428190903060095

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Histomorphologic Spectrum in Hyaline Vascular Variant of Castleman Disease.

Authors:  Chaithra Gowthuvalli Venkataramana; Hema Kini; Debarshi Saha; Sharada Rai; Deepa Sowkur Anandarama Adiga; Ranjitha Rao; Cheryl Sarah Philipose
Journal:  J Clin Diagn Res       Date:  2017-08-01

2.  Clinical and molecular characteristics of unicentric mediastinal Castleman disease.

Authors:  Antoine Legras; Anne Tallet; Audrey Didelot; Aurélie Cazes; Claire Danel; Angela Hin; Raphaël Borie; Bruno Crestani; Yves Castier; Patrick Bagan; Françoise Le Pimpec-Barthes; Marc Riquet; Hélène Blons; Pierre Mordant
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Clinical features and outcomes in patients with human immunodeficiency virus-negative, multicentric Castleman's disease: a single medical center experience.

Authors:  Seyoung Seo; Changhoon Yoo; Dok Hyun Yoon; Shin Kim; Jung Sun Park; Chan-Sik Park; Jooryung Huh; Cheolwon Suh
Journal:  Blood Res       Date:  2014-12-23

4.  Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview.

Authors:  Celina Wakisaka Maruta; Denise Miyamoto; Valeria Aoki; Ricardo Gomes Ribeiro de Carvalho; Breno Medeiros Cunha; Claudia Giuli Santi
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

5.  Historical and pathological overview of Castleman disease.

Authors:  Midori Filiz Nishimura; Yoshito Nishimura; Asami Nishikori; Tadashi Yoshino; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-04-27

6.  Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease.

Authors:  Wenhui Chen; Ling Zhao; Lijuan Guo; Li Zhao; Hongtao Niu; Huifang Lian; Huaping Dai; Jingyu Chen; Chen Wang
Journal:  Clin Respir J       Date:  2022-01-21       Impact factor: 1.761

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.